✦ LIBER ✦

The influence of intracellular epidermal growth factor receptor (EGFR) signal activation on the outcome of EGFR tyrosine kinase inhibitor treatment for pulmonary adenocarcinoma

✍ Scribed by Daigo Kawano; Tokujiro Yano; Fumihiro Shoji; Kensaku Ito; Yosuke Morodomi; Akira Haro; Naoko Miura; Tomoyoshi Takenaka; Ichiro Yoshino; Yoshihiko Maehara

Book ID: 113049876
Publisher: Springer
Year: 2011
Tongue: English
Weight: 299 KB
Volume: 41
Category: Article
ISSN: 1436-2813
DOI: 10.1007/s00595-011-4514-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

316 Cetuximab-induced clearance of the e

316 Cetuximab-induced clearance of the epidermal growth factor receptor (EGFR) overcomes resistance of cancer cells to EGFR tyrosine kinase (TK) inhibitors

✍ A. Jimeno; D. Oppenheimer; M.L. Amador; A. Maitra; M. Hidalgo 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Mutations in the epidermal growth factor

Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers

✍ Takayuki Fukui; Tetsuya Mitsudomi 📂 Article 📅 2008 🏛 Springer Japan 🌐 Japanese ⚖ 265 KB

Synthesis and antiproliferative activiti

Synthesis and antiproliferative activities against Hep-G2 of salicylanide derivatives: potent inhibitors of the epidermal growth factor receptor (EGFR) tyrosine kinase

✍ Zhu, Zhen-Wei; Shi, Lei; Ruan, Xiao-Ming; Yang, Ying; Li, Huan-Qiu; Xu, Suo-Ping 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 800 KB

ZD1839 (Iressa), a novel epidermal growt

ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression

✍ Neil G. Anderson; Tawhid Ahmad; Kai Chan; Richard Dobson; Nigel J. Bundred 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 192 KB 👁 1 views

Overexpression of the growth factor receptors EGFR and erbB2 occurs frequently in several human cancers and is associated with aggressive tumour behaviour and poor patient prognosis. We have investigated the effects of ZD1839 (Iressa), a novel EGFR tyrosine kinase inhibitor, on the growth, in vitro

Improvement of psoriasis and cutaneous s

Improvement of psoriasis and cutaneous side-effects during tyrosine kinase inhibitor therapy for renal metastatic adenocarcinoma. A role for epidermal growth factor receptor (EGFR) inhibitors in psoriasis?

✍ E. Wierzbicka; J.M. Tourani; G. Guillet 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

ChemInform Abstract: Tyrosine Kinase Inh

ChemInform Abstract: Tyrosine Kinase Inhibitors. Part 9. Synthesis and Evaluation of Fused Tricyclic Quinazoline Analogues as ATP Site Inhibitors of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR).

✍ G. W. REWCASTLE; B. D. PALMER; A. J. BRIDGES; H. D. H. SHOWALTER; L. SUN; J. NEL 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB